Clinical Trials Directory

Trials / Unknown

UnknownNCT05471388

Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients \& the relation between metabolic syndrome in acne vulgaris and level of asprosin.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum asprosinassessment of serum asprosin by a commercially available double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) kit.

Timeline

Start date
2022-07-18
Primary completion
2023-01-18
Completion
2023-01-18
First posted
2022-07-22
Last updated
2022-07-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05471388. Inclusion in this directory is not an endorsement.